unichem laboratories ltd (UL:Natl India)
unichem laboratories ltd (UL) Snapshot
|
Open
168.00
|
Previous Close
170.05
|
|
|
Day High
171.85
|
Day Low
168.00
|
|
|
52 Week High
01/10/13 - 216.90
|
52 Week Low
06/4/12 - 122.40
|
|
|
Market Cap
20.2B
|
Average Volume 10 Days
65.3K
|
|
|
EPS TTM
12.52
|
Shares Outstanding
118.8M
|
|
|
EX-Date
--
|
P/E TM
13.6x
|
|
|
Dividend
4.50
|
Dividend Yield
1.77%
|
Related News
unichem laboratories ltd (UL) Related Businessweek News
No Related Businessweek News Foundunichem laboratories ltd (UL) Details
Unichem Laboratories Limited manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in India, the European Union, the Americas, and rest of the world. It offers various formulation products that address a range of therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, dermatology/cosmetology, nephrology, rheumatology, anti-infectives, central nervous system, ENT, and generics. The company was founded in 1944 and is based in Mumbai, India.
unichem laboratories ltd (UL) Top Compensated Officers
unichem laboratories ltd (UL) Key Developments
Unichem Laboratories Limited announced that the Board of Directors of the Company at its meeting held on May 11, 2013, has recommended Dividend of INR 4.50 (225%) per equity share of INR 2 each, for the year ended March 31, 2013, subject to approval of Shareholders at ensuring Annual General Meeting.
Unichem Laboratories Limited reported unaudited standalone earnings results for the fourth quarter and full year ended March 31, 2013 and consolidated earnings results for the full year ended March 31, 2013. For the quarter, on standalone basis net sales /income from operations was INR 2,412.3 million compared to INR 1,903.6 million a year ago. Profit from operations before other income, interest and exceptional items was INR 320.2 million compared to INR 251.4 million a year ago. Profit from ordinary activities before tax was INR 347.6 million against INR 260.0 million a year ago. Net profit was INR 310.3 million or INR 3.42 diluted per share against INR 232.3 million or INR 2.56 diluted per share a year ago. For the year to date, on standalone basis net sales /income from operations was INR 9,968.5 million compared to INR 7,939.0 million a year ago. Profit from operations before other income, interest and exceptional items was INR 1,508.6 million compared to INR 1,359.4 million a year ago. Profit from ordinary activities before tax was INR 1,624.4 million against INR 1,052.3 million a year ago. Net profit was INR 1,295.9 million or INR 14.29 diluted per share against INR 824.6 million or INR 9.09 diluted per share a year ago. For the quarter, on consolidated basis net sales /income from operations was INR 10,724.4 million compared to INR 8,661.8 million a year ago. Profit from operations before other income, interest and exceptional items was INR 1,359.4 million compared to INR 879.0 million a year ago. Profit from ordinary activities before tax was INR 1,460.7 million against INR 940.2 million a year ago. Net profit was INR 1,132.2 million or INR 12.48 diluted per share against INR 712.5 million or INR 7.86 diluted per share a year ago.
Unichem Laboratories Limited announced that they will report fiscal year 2013 results on May 11, 2013
| Recently Viewed | |||
| UL:IN | 169.70 INR | -0.35 | |
| Company | Last | Change | |
| No competitor information is available for UL. | |||
| View Industry Companies | |||
Industry Analysis
UL
Industry Average
| Valuation | UL | Industry Range |
| Price/Earnings | -- | Not Meaningful |
| Price/Sales | -- | Not Meaningful |
| Price/Book | -- | Not Meaningful |
| Price/Cash Flow | -- | Not Meaningful |
| TEV/Sales | -- | Not Meaningful |
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact UNICHEM LABORATORIES LTD, please visit www.unichemindia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








